ScoreWhy is Sanofi Consumer Healthcare India Ltd ?
1
High Management Efficiency with a high ROE of 67.74%
2
The company is Net-Debt Free
3
Poor long term growth as Net Sales has grown by an annual rate of 10.10% and Operating profit at 5.70% over the last 5 years
4
The company has declared Positive results for the last 3 consecutive quarters
- NET SALES(Latest six months) At Rs 480.20 cr has Grown at 39.88%
- PAT(Q) Highest at Rs 67.80 cr.
- EPS(Q) Highest at Rs 29.48
5
With ROE of 65.8, it has a Very Expensive valuation with a 28.3 Price to Book Value
- Over the past year, while the stock has generated a return of -7.24%, its profits have fallen by 0% ; the PEG ratio of the company is 2.6
6
High Institutional Holdings at 20.33%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Sanofi Consumer should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Sanofi Consumer for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Sanofi Consumer
-7.24%
-0.19
37.86%
Sensex
-5.98%
-0.45
13.24%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
10.10%
EBIT Growth (5y)
5.70%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.98
Sales to Capital Employed (avg)
2.77
Tax Ratio
25.07%
Dividend Payout Ratio
71.85%
Pledged Shares
0
Institutional Holding
20.33%
ROCE (avg)
-178.66%
ROE (avg)
67.74%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
43
Industry P/E
34
Price to Book Value
28.32
EV to EBIT
32.72
EV to EBITDA
31.45
EV to Capital Employed
1193.04
EV to Sales
11.23
PEG Ratio
2.61
Dividend Yield
NA
ROCE (Latest)
2862.50%
ROE (Latest)
65.84%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Bullish (Daily)
KST
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend12What is working for the Company
NET SALES(Latest six months)
At Rs 480.20 cr has Grown at 39.88%
PAT(Q)
Highest at Rs 67.80 cr.
EPS(Q)
Highest at Rs 29.48
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Sanofi Consumer
Profit After Tax (PAT) - Quarterly
Highest at Rs 67.80 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Latest six months
At Rs 480.20 cr has Grown at 39.88%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 29.48
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Sanofi Consumer
Non Operating Income - Quarterly
Highest at Rs 5.60 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
